Mesenchymal Stem Cell Market Report: Trends, Forecast and Competitive Analysis to 2030

Mesenchymal Stem Cell Trends and Forecast

The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets. The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030 with a CAGR of 13.1% from 2024 to 2030. The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

A more than 150-page report is developed to help in your business decisions.

Mesenchymal Stem Cell by Segment

The study includes a forecast for the global mesenchymal stem cell by workflow, type, application, and region.

Mesenchymal Stem Cell Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

• Cell Sourcing & Isolation
• Culture & Cryopreservation
• Differentiation
• Characterization

Mesenchymal Stem Cell Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Autologous
• Allogeneic

Mesenchymal Stem Cell Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Disease Modelling
• Drug Development & Discovery
• Stem Cell Banking
• Tissue Engineering
• Toxicology Studies
• Others

Mesenchymal Stem Cell Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Mesenchymal Stem Cell Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mesenchymal stem cell companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mesenchymal stem cell companies profiled in this report include-

• Thermo Fisher Scientific
• Cell Applications
• Axol Biosciences
• Cytori Therapeutics
• STEMCELL Technologies
• Cyagen Biosciences
• Celprogen
• Brainstorm Cell
• Stemedica Cell Technologies
• Merck

Mesenchymal Stem Cell Market Insights

Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Features of the Global Mesenchymal Stem Cell Market

Market Size Estimates: Mesenchymal stem cell market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Mesenchymal stem cell market size by workflow, type, application, and region in terms of value ($B).

Regional Analysis: Mesenchymal stem cell market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different workflow, type, application, and regions for the mesenchymal stem cell market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mesenchymal stem cell market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the mesenchymal stem cell market size?

Answer: The global mesenchymal stem cell market is expected to reach an estimated $6.6 billion by 2030.

Q.2 What is the growth forecast for mesenchymal stem cell market?

Answer: The global mesenchymal stem cell market is expected to grow with a CAGR of 13.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the mesenchymal stem cell market?

Answer: The major drivers for this market are rising incidence of chronic conditions including diabetes, cancer, and autoimmune illnesses, growing appeal of regenerative medicine, and surge in research and development efforts by biopharmaceutical firms to create innovative therapies utilizing mesenchymal stem cells.

Q4. What are the major segments for mesenchymal stem cell market?

Answer: The future of the global mesenchymal stem cell market looks promising with opportunities in the disease modelling, drug development & discovery, stem cell banking, tissue engineering, and toxicology study markets.

Q5. Who are the key mesenchymal stem cell market companies?

Answer: Some of the key mesenchymal stem cell companies are as follows:

• Thermo Fisher Scientific
• Cell Applications
• Axol Biosciences
• Cytori Therapeutics
• STEMCELL Technologies
• Cyagen Biosciences
• Celprogen
• Brainstorm Cell
• Stemedica Cell Technologies
• Merck

Q6. Which mesenchymal stem cell market segment will be the largest in future?

Answer: Lucintel forecasts that allogeneic will remain the larger segment over the forecast period due to strong safety track record of allogeneic mesenchymal stem cells in clinical use is noteworthy, and transplantation of allogeneic MSCs is poised to become a groundbreaking cell-based therapeutic method owing to its low potential for triggering immune responses and its immunosuppressive properties.

Q7. In mesenchymal stem cell market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period because the significant volume of clinical trials is currently in progress within the United States, aimed at evaluating the effectiveness and safety of mesenchymal stem cells as a potential treatment option for various life-threatening diseases.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the mesenchymal stem cell market by workflow (cell sourcing & isolation, culture & cryopreservation, differentiation, and characterization), type (autologous and allogeneic), application (disease modelling, drug development & discovery, stem cell banking, tissue engineering, toxicology studies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?